Tuyet Nguyen
Medical · Las Vegas, NVNPI 1396974671
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.6% of the total across 221 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 221 payments — averaging $38.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1K
- Amgen$876
- Biohaven Pharmaceuticals, Inc.$800
- AstraZeneca$584
- Novo Nordisk$567
- Boston Scientific$423
- plus $4K from 27 others
What the payments were for
- Consulting fees$8009%
- Food & beverage$7,68291%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 24 | $1,389 |
| Amgen(2 entities) | 22 | $876 |
| Biohaven Pharmaceuticals, Inc. | 1 | $800 |
| AstraZeneca | 14 | $584 |
| Novo Nordisk | 22 | $567 |
| Boston Scientific | 15 | $423 |
| Intra-sana Laboratories | 5 | $350 |
| Lucid Diagnostics Inc. | 8 | $280 |
| W. L. Gore & Associates, Inc. | 2 | $243 |
| Phathom Pharmaceuticals, Inc. | 7 | $241 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $233 |
| Dexcom, Inc. | 9 | $230 |
| Boehringer Ingelheim | 10 | $219 |
| Pfizer | 11 | $215 |
| Lilly USA, LLC | 13 | $214 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $208 |
| Bayer | 4 | $170 |
| Exact Sciences | 10 | $158 |
| Asahi Intecc USA, Inc. | 1 | $155 |
| Astellas Pharma US Inc | 2 | $152 |
| Nevro Corp. | 2 | $150 |
| Johnson & Johnson | 1 | $123 |
| AbbVie | 1 | $102 |
| Daiichi Sankyo Inc. | 5 | $98 |
| Idorsia Pharmaceuticals US Inc | 3 | $53 |
| Genentech USA, Inc. | 3 | $47 |
| GSK | 3 | $43 |
| Medline Industries LP | 1 | $43 |
| Tactile Systems Technology Inc | 2 | $32 |
| Merck | 2 | $31 |
| Inogen, Inc. | 1 | $21 |
| Amarin Pharma, Inc. | 1 | $20 |
| Phadia US Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$924
- FreeStyle Libre 2$580
- Reltone 200 Mg$320
- GLYCATE$320
- Reltone 400 Mg$320
- PROCLAIM$289
- Repatha$255
- FREESTYLE LIBRE 3$215
- PERIPHERAL VASCULAR$155
- GORE CARDIOFORM Septal Occluder$149
- DEXCOM G7 GSS (161)$144
- DEXCOM STELO GLUCOSE BIOSENSOR$144
- Senza$138
- CAPLYTA$127
- Veozah$125
- BRILINTA$125
- FARXIGA$124
- XARELTO$123
- Kerendia$122
- AIMOVIG$121
How this compares
$8,482 in reported general payments places this provider in the 90th percentile of 250 medical providers in Nevada.
Other medical in Las Vegas
- John NotabartoloLas Vegas$284K
- Rachel BowersLas Vegas$29K
- Spencer MeierLas Vegas$24K
- Megan WieselLas Vegas$19K
- Tai PhamLas Vegas$16K
- Eric HilmesLas Vegas$15K
- Wardon OjedapoLas Vegas$12K
- Melchor GochiocoLas Vegas$11K
- Keesha KaplanLas Vegas$11K
- Adelbert WadsworthLas Vegas$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.